SCHEMBL24851336

SCHEMBL24851336

CCOC(=O)c1cnc(Cl)nc1NC(C)(C)CO

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 4/20 0.48
▸ NFKB1 P19838 7/20 0.43
▸ FOS P01100 6/20 0.43
▸ JUN P05412 6/20 0.43
▸ NFKB2 Q00653 6/20 0.43
▸ RELA Q04206 6/20 0.43
▸ ATF1 P18846 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23625406 0.87 SYK (0.50) SYKNFKB1FOSJUNNFKB2
SCHEMBL23620399 0.81 SYK (0.54) SYKNFKB1FOSJUNNFKB2
SCHEMBL14810384 0.81 KDM4E (0.57) SYKNFKB1FOSJUNNFKB2
SCHEMBL2523948 0.80 SYK (0.53) SYKNFKB1FOSJUNNFKB2
SCHEMBL22866255 0.78 ALDH1A1 (0.55) SYKNFKB1FOSJUNNFKB2
SCHEMBL17764556 0.78 SYK (0.51) SYKNFKB1FOSJUNNFKB2
SCHEMBL18341477 0.78 IRAK4 (0.41) KDM4EALDH1A1MAPTNPC1MEN1
SCHEMBL29076116 0.77 ALDH1A1 (0.49) SYKNFKB1FOSJUNNFKB2
SCHEMBL10050288 0.76 NR2F2 (0.56) SYKNFKB1FOSJUNNFKB2
SCHEMBL18168237 0.76 PDE4B (0.50) SYKNFKB1FOSJUNNFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023278483-A1 COMPOUNDS HAVING 1H-PYRAZOLO[4,3-C]PYRIDIN-6-AMINOS AS THERAPEUTIC AGENTS LOMOND THERAPEUTICS, INC. (US) 2023-01-05 — — WO disclosed
WO-2023278483-A1 COMPOUNDS HAVING 1H-PYRAZOLO[4,3-C]PYRIDIN-6-AMINOS AS THERAPEUTIC AGENTS LOMOND THERAPEUTICS, INC. (US) 2023-01-05 — — WO disclosed
Send feedback